KOLINSKI STUART 4
4 · REGENERON PHARMACEUTICALS INC · Filed Feb 4, 2010
Insider Transaction Report
Form 4
KOLINSKI STUART
SVP General Counsel and Secret
Transactions
- Tax Payment
Common Stock
2010-02-02$27.16/sh−103$2,797→ 10,797 total - Tax Payment
Common Stock
2010-02-02$27.16/sh−2,734$74,255→ 16,803 total - Tax Payment
Common Stock
2010-02-02$27.16/sh−785$21,321→ 16,014 total - Sale
Common Stock
2010-02-03$27.66/sh−4,951$136,945→ 10,613 total - Exercise/Conversion
Common Stock
2010-02-02$8.50/sh+416$3,536→ 11,029 total - Tax Payment
Common Stock
2010-02-02$27.16/sh−2,174$59,046→ 14,629 total - Tax Payment
Common Stock
2010-02-02$27.16/sh−988$26,834→ 16,799 total - Sale
Common Stock
2010-02-03$28.08/sh−450$12,636→ 15,564 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-02-02−3,158→ 0 totalExercise: $8.50Exp: 2011-01-05→ Common Stock (3,158 underlying) - Tax Payment
Common Stock
2010-02-02$27.16/sh−129$3,504→ 10,900 total - Exercise/Conversion
Common Stock
2010-02-02$8.50/sh+8,740$74,290→ 19,537 total - Exercise/Conversion
Common Stock
2010-02-02$8.50/sh+3,158$26,843→ 17,787 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-02-02−416→ 11,898 totalExercise: $8.50Exp: 2011-01-05→ Common Stock (416 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-02-02−8,740→ 3,158 totalExercise: $8.50Exp: 2011-01-05→ Common Stock (8,740 underlying)
Holdings
- 3,294(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The reporting person sold 4,951 shares of Company stock on February 3, 2010 at prices ranging from $27.42to $27.98. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on February 3, 2010 at each separate price.
- [F3]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- [F4]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.